{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for methyl root_modifications_structuralModifications_molecularFragment_refPname in root_modifications_structuralModifications_molecularFragment_refPname (approximate match)
Status:
US Approved Rx
(2021)
Source:
NDA215014
(2021)
Source URL:
First approved in 2021
Source:
NDA215014
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2014)
Source:
BLA125499
(2014)
Source URL:
First approved in 2014
Source:
BLA125499
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01157065: Phase 2 Interventional Completed Exudative Age-Related Macular Degeneration
(2011)
Source URL:
Class:
PROTEIN
Class:
PROTEIN
Avicatonin (chicken carbocalcitonin), a calcitonin stimulant that participated in clinical trials to check its analgesic effect on patients with osteoporosis or osteopenia and backache. As a result, avicatonin has shown only a placebo effect. Besides, avicatonin has hypocalcemic activity due to the inhibition of both the generation and function of osteoclasts.
Status:
Investigational
Source:
USAN:HEMOGLOBIN GLUTAMER-256 (HUMAN) [USAN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
NUCLEIC ACID
Status:
Investigational
Class:
NUCLEIC ACID
Status:
Investigational
Class:
NUCLEIC ACID
